Journal of Urology

The May 2026 Journal of Urology® is here! Stay current with cutting-edge research, clinical insights and global literature in the most cited journal in the field! 🔗 Read now: bit.ly/41UycT1

What does success really look like in complex urinary diversion surgery? In this comment, the authors frame colon conduit urinary diversion as a necessary but demanding alternative when ileum isn’t feasible—emphasizing high complication rates driven more by patient physiology than technique, the importance of preoperative optimization, and the need for vigilant long‑term follow‑up. 🔗 Click to read more: bit.ly/4cFvWW9

When ileum isn’t an option, how safe is using colon for urinary diversion? In this article, a large multi‑institutional study shows that colon conduit urinary diversion can be performed without worse short‑term outcomes—even with a concurrent colonic anastomosis—while highlighting the importance of preoperative nutrition in reducing complications. 🔗 Click to read more: bit.ly/4mXDN4R

Can molecular imaging reliably guide renal mass decision‑making? In this comment, the authors emphasize the promise of 99mTc‑sestamibi SPECT/CT as a noninvasive screening tool to help rule out aggressive renal cancers—while cautioning that overlap between benign and malignant imaging patterns means it should complement, not replace, other diagnostic approaches. 🔗 Click to read more: bit.ly/4td000o

Can molecular imaging better distinguish benign from aggressive kidney tumors? In this article, researchers show that 99mTc‑sestamibi SPECT/CT can effectively risk‑stratify indeterminate renal masses—helping identify benign or indolent tumors while flagging aggressive RCCs to better guide shared decision‑making. 🔗 Click to read more: bit.ly/3P8LZCI

Does earlier varicocelectomy change long‑term fertility outcomes? In this comment, the author underscores the importance of long‑term data linking early varicocelectomy to improved adult testicular growth and semen parameters—highlighting how timely intervention may mitigate progressive injury while calling for continued prospective research to refine surgical timing guidelines. 🔗 Click to read more: bit.ly/4egJsRe

Does timing matter when treating varicoceles in young patients? In this article, long‑term data show that varicocelectomy in children and adolescents is associated with improved testicular growth and higher sperm counts into adulthood—especially when surgery is performed earlier rather than later. 🔗 Click to read more: bit.ly/4cFu5k9

Can advanced imaging reduce overtreatment of small renal masses? In this comment, the author highlights how CAIX‑targeted PET/CT with [⁸⁹Zr]Zr‑girentuximab could meaningfully reduce unnecessary surgery and biopsies—while also raising important concerns about real‑world cost, logistics, and implementation as this promising diagnostic approach moves closer to practice. 🔗 Click to read more: bit.ly/4umayLD

Can advanced imaging reduce overtreatment of small renal masses—and still be cost‑effective? In this article, researchers show that incorporating [⁸⁹Zr]Zr‑girentuximab PET‑CT into care can help avoid unnecessary biopsies and treatment of benign tumors while remaining a cost‑effective strategy for managing small renal masses. 🔗 Click to read more: bit.ly/4ePiUqg

Do we need hemostatic agents in robotic partial nephrectomy? Thank you @AndrewHarris_MD for your insights on, "Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial Nephrectomy," from the May issue of JU. 🔗 bit.ly/48rr5Fm

Can patient‑reported outcomes after stent placement be measured better? In this comment, the authors commend the patient‑centered design and practicality of the Canadian Endourology Group Stent Symptom Score while emphasizing the need for further validation—particularly around how clinicians can apply the tool in everyday practice and across broader stent populations. 🔗 Click to read more: bit.ly/4w51vjR

Are common urodynamic tools giving us the full picture? In this article, researchers directly compare patch versus needle electromyography and find that surface patch EMG frequently misses key urinary sphincter findings—raising concern for misdiagnosis and underscoring when needle EMG may be essential for pediatric care. 🔗 Click to read more: bit.ly/49eWA5M

Can less invasive bladder tumor treatment deliver the same cancer control? In this comment, the authors highlight level‑1 evidence showing that office‑based laser coagulation is oncologically noninferior to TURBT for recurrent low‑grade Ta tumors—while also noting real‑world barriers to adoption and reinforcing its role as a safe, patient‑friendly alternative when resources allow. 🔗 Click to read more: bit.ly/4n058U7

Dr. Amanda Black talks about her randomized clinical trial and how it shows that office-based laser photocoagulation is noninferior to TURBT at 12 months—offering a safe, efficient alternative that avoids general anesthesia and the OR for many patients 🔗bit.ly/4sryOud

Can bladder cancer treatment move safely out of the OR? In this article, a randomized clinical trial shows that in-office laser coagulation for recurrent Ta low‑grade bladder tumors is noninferior to standard TURBT at 12 months—offering similar cancer control with a less invasive, patient‑friendly approach. 🔗 Click to read more: bit.ly/4sryOud

Are we using costly surgical tools without clear benefit? In this comment, the author reflects on new randomized trial data showing no measurable advantage to routine hemostatic agent use in robotic partial nephrectomy—and urges surgeons to rethink entrenched habits, cost, and reliance on anecdotal experience when evidence tells a different story. 🔗 Click to read more: bit.ly/4ebQTcp

Do hemostatic agents really reduce bleeding in robotic kidney surgery? In this article, a randomized trial found no meaningful difference in blood loss or major bleeding complications with routine hemostatic agent use during robotic-assisted laparoscopic partial nephrectomy—calling a common practice into question. 🔗 Click to read more: bit.ly/48rr5Fm

Dirty air, real consequences! Thank you @RenaMalikMD for insights on, "Air Pollution, Lifestyle, and Genetic Risk: A Multidimensional Study of PM2.5 Constituents and Prostate Cancer," from the May issue of JU. 🔗 Click to read more: bit.ly/4t9YvAA

Air pollution isn’t just background noise—it’s a risk factor In this article, a large UK Biobank study identifies specific PM2.5 components associated with increased prostate cancer risk, even after accounting for genetic susceptibility and lifestyle 🔗 bit.ly/4t9YvAA

How consistent is prostate cancer grading—really? In this article, the authors report the first telepathology concordance study using contemporary ISUP criteria, highlighting variability that may influence surveillance versus treatment decisions. 🔗 bit.ly/3OSgigS

Dr. Naeem Bhojani and colleagues introduce the Canadian Endourology Group Stent Symptom Score (CEGSSS)—a validated, 11‑item tool designed specifically for stents indwelling less than two weeks, reducing burden for both patients and clinicians. 🔗 bit.ly/3OWcWcJ